Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
mediator complex subunit 1 | 0.573 | 0.692 | 1.00 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
myocardin | 0.619 | 0.615 | 0.33 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2003 | 2003 | ||||||||
|
dynamin 1 like | 0.475 | 0.808 | 5.7E-04 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2002 | 2002 | ||||||||
|
integrin linked kinase | 0.503 | 0.769 | 3.8E-05 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
estrogen related receptor beta | 0.565 | 0.846 | 0.13 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
MAS related GPR family member D | 0.861 | 0.192 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | |||||||||
|
dystroglycan 1 | 0.498 | 0.808 | 0.98 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2004 | 2004 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2015 | ||||||||
|
ribosomal protein S6 kinase B1 | 0.511 | 0.731 | 0.97 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
MAS1 proto-oncogene, G protein-coupled receptor | 0.533 | 0.769 | 8.3E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
tubulin beta class I | 0.603 | 0.692 | 0.98 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
C-X-C motif chemokine receptor 3 | 0.436 | 0.808 | 0.18 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
leiomodin 2 | 0.805 | 0.154 | 5.5E-04 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
cathepsin V | 0.716 | 0.462 | 2.3E-07 |
|
group | 0.200 | None | 0 | 0 |